|
C14ORF147 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.530800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.809600E-01 |
| Normal-vs-Stage2 |
9.948600E-01 |
| Normal-vs-Stage3 |
7.326000E-01 |
| Normal-vs-Stage4 |
9.866800E-01 |
| Stage1-vs-Stage2 |
9.162000E-01 |
| Stage1-vs-Stage3 |
5.629800E-01 |
| Stage1-vs-Stage4 |
8.908400E-01 |
| Stage2-vs-Stage3 |
7.843200E-01 |
| Stage2-vs-Stage4 |
9.845600E-01 |
| Stage3-vs-Stage4 |
7.897600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.099000E-01 |
| Normal-vs-AfricanAmerican |
1.475230E-01 |
| Normal-vs-Asian |
3.272000E-01 |
| Caucasian-vs-AfricanAmerican |
1.151550E-01 |
| Caucasian-vs-Asian |
2.646400E-01 |
| AfricanAmerican-vs-Asian |
3.909600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.638600E-01 |
| Normal-vs-Female |
9.535000E-01 |
| Male-vs-Female |
9.964600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.103200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.342200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.947000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.108200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.014600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.353800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.613400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.415800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.434600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.814800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.095600E-03 |
| Classical-VS-Follicular |
1.172970E-01 |
| Classical-VS-Other |
7.127200E-01 |
| Classical-VS-Normal |
8.063600E-01 |
| Tall-VS-Follicular |
4.172300E-04 |
| Tall-VS-Other |
3.731000E-01 |
| Tall-VS-Normal |
1.515910E-02 |
| Follicular-VS-Other |
3.373800E-01 |
| Follicular-VS-Normal |
2.880400E-01 |
| Other-VS-Normal |
5.900800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.154400E-01 |
| Normal-vs-N1 |
1.091220E-01 |
| N0-vs-N1 |
1.074330E-02 |
|
|
